Related Experiment Video
Updated: Sep 8, 2025

Sexual Development and Ascospore Discharge in Fusarium graminearum
Published on: March 29, 2012
A new strain of Fusarium sp. with antimicrobial activity
Xochitl Morales-de la Cruz1, Leonardo Serrano-Márquez1, Guillermo Mendoza2
1Instituto de Ecología, A. C., Red de Biodiversidad y Sistemática. Carretera Antigua a Coatepec No. 351, El Haya, 91073, Xalapa, Veracruz, Mexico.
Abstract:
Fungi have been considered important in the development of new pharmaceuticals and agricultural compounds due to their metabolic diversity. In this study, a fungus associated with Lactarius aff. fragilis was isolated. Strain PH130 was molecularly identified by analyzing the ITS and tef1-α regions, which belongs to a strain of Fusarium sp. Phylogenetic results showed that it is evolutionarily related to F. beomiforme. The aim of this study was to evaluate the antimicrobial activities of strain PH130 against fungi and bacteria of agricultural and clinical interest. The results of dual confrontation assays demonstrate that strain PH130 has biological activity against phytopathogenic fungal strains of Acremonium strictum (CBF-230), Colletotrichum asianum (CBF-339) and Fusarium oxysporum (ATCC-16417) with an inhibition percentage of 96 %, 100 % and 75 % respectively; the PH130-CM30 extract showed MIC and MFC at 500 μg/mL against the yeast Candida tropicalis (CECT 1440), which is of clinical interest. In addition, PH130-C15 and PH130-A15 extracts showed MIC at 125 μg/mL and MBC at 250 μg/mL against C. michiganensis respectively (ID/46). Furthermore, PH130-A15 extract showed MIC at 1000 μg/mL against Pseudomonas syringae (ID/17) and the extracts PH130-C15 and PH130-C30 showed activity against the human pathogenic bacteria Enterococcus faecalis (ATCC 29212) and Staphylococcus aureus (ATCC 25923) with MIC at 250 μg/mL. Additionally, PH130-C30 chloroform extracts showed MBC at 500 μg/mL against S. aureus. Regarding toxicity, the extracts showed moderate and high toxicity within an LC50 range of <100-500 μg/mL against Artemia salina. Herein, we report for the first time the extracts of Fusarium sp. strain PH130 and provides preliminary information on their antimicrobial potential. The bioactivity of the PH130 strain extracts opens the possibility of future research to identify bioactive compounds.
Insights
This study identified Fusarium sp. strain PH130, revealing its potent antimicrobial activity against agricultural and clinical pathogens. Extracts demonstrated significant inhibition of fungi and bacteria, suggesting potential for novel drug discovery.
Area of Science:
- Microbiology
- Mycology
- Biotechnology
Background:
- Fungi are a rich source of diverse metabolites with pharmaceutical and agricultural applications.
- Metabolic diversity in fungi drives the search for novel bioactive compounds.
- Strain PH130, a fungus associated with Lactarius aff. fragilis, was isolated for investigation.
Purpose of the Study:
- To molecularly identify and phylogenetically place isolated fungal strain PH130.
- To evaluate the antimicrobial potential of Fusarium sp. strain PH130 extracts against agricultural and clinical pathogens.
- To assess the preliminary toxicity of the fungal extracts.
Main Methods:
- Molecular identification using ITS and tef1-α regions.
- Phylogenetic analysis to determine evolutionary relationships.
- Antimicrobial activity assays including dual confrontation, determination of Minimum Inhibitory Concentration (MIC), and Minimum Bactericidal Concentration (MBC).
- Toxicity assessment using brine shrimp lethality assay (LC50).
Main Results:
- Strain PH130 was identified as Fusarium sp., evolutionarily related to F. beomiforme.
- Significant inhibition of phytopathogenic fungi: Acremonium strictum (96%), Colletotrichum asianum (100%), Fusarium oxysporum (75%).
- Effective activity against clinical yeast Candida tropicalis (MIC/MFC 500 μg/mL).
- Antimicrobial activity against plant pathogen C. michiganensis (MIC 125 μg/mL, MBC 250 μg/mL) and human pathogens Enterococcus faecalis and Staphylococcus aureus (MIC 250 μg/mL).
- Moderate to high toxicity observed (LC50 <100-500 μg/mL) against Artemia salina.
Conclusions:
- Fusarium sp. strain PH130 exhibits significant antimicrobial properties against a range of agricultural and clinical pathogens.
- The study provides the first report on the extracts of Fusarium sp. strain PH130, highlighting their antimicrobial potential.
- These findings open avenues for future research into identifying specific bioactive compounds from this fungal strain for drug development.
More Related Videos
09:21Inhibition of Aspergillus flavus Growth and Aflatoxin Production in Transgenic Maize Expressing the α-amylase Inhibitor from Lablab purpureus L.
Published on: February 15, 2019
11:48A Contrast of Three Inoculation Techniques used to Determine the Race of Unknown Fusarium oxysporum f.sp. niveum Isolates
Published on: October 28, 2021
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Antimicrobial Effectiveness
Fungal Group Zygomycota